Eileen Burbidge31:33
Hopefully, given I've done it before, it is possible that I would never let them down and I'm still trying to do right by them, looking after the Passion value drivers and portfolio companies as much as I can. Hopefully it's also somewhat reassuring that Fertifa is a Passion Fund Three company, so that's how it started. You asked earlier about doing the dual hat of Monzo and Passion in 2020. We invested in Fertifa in October 2020, during lockdown and the pandemic. We were still making new investments. We closed the fund first in August 2019, with a second closing in August 2020. We came across Fertifa, made that investment, and really believed in the vision, purpose, and market. That's a whole other podcast, but I have talked about why my personal journey has me gravitating towards supporting reproductive health and investing in areas that have been historically under-invested. It's a great shame. I had been keeping an eye out, surveyed the market, talked to most startups that are still around. We came across Fertifa and liked the proposition. I'm also a personal angel investor in US-based Maven Clinic. I love Kate Ryder, who had been based in London before going to New York. I've seen what she and Kindbody have done in the US for this category. In my research, I realized that eight times as much money is spent today across Europe in assisted reproductive technology than in the US, yet there are three unicorns in the US in this category and there isn't a category leader yet in Europe. As an investor, this seems to be a very big market. It makes a lot of sense. Because I was born and raised in America, I am used to non-public funded healthcare or private pay healthcare. I'm also hugely sensitive to the rollback of reproductive healthcare rights in America and in certain states. I'm very concerned about future access. I've had 20 years benefiting from the NHS here, but I think culturally we've developed a false sense of comfort that the NHS or public healthcare across Europe will look after us. It hasn't ever always been completely inclusive. It's always had cost constraints or budget constraints, so restrictions. You might have qualified for three rounds of IVF on the NHS if you were of a certain age, under a certain BMI, didn't have children from a previous relationship, were married, and not in a same-sex relationship. That hasn't been the case. Coming off the pandemic, it was clear the NHS was on its knees with record wait times. There's an obvious case that we will need different types of privately funded healthcare throughout the UK and Europe. That's not where we started with Fertifa. We started with companies finally recognizing a duty to employee well-being during the pandemic. We no longer pretend we don't have children, families, dogs, or pets because everyone's seeing it on Zoom calls. We have to look after well-being. Reproductive health matters are hugely distracting and debilitating for productivity. If employers really want to look after people, they need to start covering these topics, which have never been covered under private medical insurance and which we weren't getting enough of through the public healthcare system. When Fertifa came along, it seemed an obvious investment thesis for a pre-seed deal. When the team said there was a bit of a shuffle needed, execution was going well, traction was going well, inbound demand was going really well, but we might need a slight rejig of the leadership team, I went in January 2022 thinking, 'No problem, I've done the Tide thing, I've done the Monzo thing. The company is seven people, that's the size of my dinner table. I can go in on internet, it'll take me three months, I'll hire somebody to be CEO like I did at Tide.' That was the original idea a year and a half ago. The team hasn't been able to get rid of me because I fell even more in love with the proposition. I saw how much demand there was. I felt it was a largely executional play but should be delivered by someone who really believes in the mission, which I really am. If somebody were to say there's a better person to run this business than me, I've had that conversation the other way, so I'm ready for that. For the moment, I feel like building this up and proving out the thesis that there should be a category leader here in Europe. We shouldn't just wait for Maven or Kindbody to come service us in the UK and Europe. We should build our own. We have the ability, capability, and talent to do that. That's what I'm really excited about doing now. There have been Fertifa babies, lots of them. We had a new Fertifa baby born three weeks ago.